An imaging tool was approved by the Food and Drug Administration in May to better detect prostate cancer and is now available at Stony Brook Hospital.
Stony Brook officials say the technique is a more advanced way to see lymph nodes, soft tissue and other signs of the disease.
It's estimated that 1 in 8 men will be diagnosed with prostate cancer in their lifetime.